Skip to main content
Clinical Trials/NCT01228981
NCT01228981
Completed
Not Applicable

Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy

Association for Innovation and Biomedical Research on Light and Image1 site in 1 country400 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type-2 Diabetic Retinopathy
Sponsor
Association for Innovation and Biomedical Research on Light and Image
Enrollment
400
Locations
1
Primary Endpoint
Phenotypes of Diabetic Retinopathy progression.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to characterize type 2 diabetic patients with initial alterations of diabetic retinopathy (DR) based on 3 different phenotypes previously identified and different patterns of progression in order to correlate this data with genetic information.

Detailed Description

This study aims to to characterize type 2 diabetic patients with initial alterations of diabetic retinopathy (DR) based on three different phenotypes previously identified and different patterns of progression \[Lobo, 2004\] in order to correlate this data with genetic information (based on a list of candidate genes previously identified as being involved in DR). The results of this study will be used exclusively for scientific purposes.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
March 2013
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Association for Innovation and Biomedical Research on Light and Image
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Type-2 diabetic subjects form the PTDC/SAU-OSM/72635/2006 clinical trial (early stages of non-proliferative retinopathy - level 30 to 35 ETDRS;. females or males; age over 18 years) with a signed Informed Consent for this study.

Exclusion Criteria

  • Cataract or other eye disease that may interfere with fundus examinations; Vitreous syneresis or posterior vitreous detachment; and Dilatation of the pupil \< 5 mm.

Outcomes

Primary Outcomes

Phenotypes of Diabetic Retinopathy progression.

Time Frame: June 2011

Study Sites (1)

Loading locations...

Similar Trials